Portal vein tumour thrombosis radiotherapy improves the treatment outcomes of immunotherapy plus bevacizumab in hepatocellular carcinoma: a multicentre real-world analysis with propensity score matching

BACKGROUND: This study aimed to evaluate the efficacy and safety of sequential immune checkpoint inhibitors (ICIs) plus bevacizumab therapy after radiotherapy for portal vein tumour thrombosis (PVTT) in patients with hepatocellular carcinoma (HCC). METHODS: Retrospective data were collected from 113...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Cuiping, He, Qin, Feng, Jian, Liao, Ziyue, Peng, Yunli, Gao, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620737/
https://www.ncbi.nlm.nih.gov/pubmed/37928530
http://dx.doi.org/10.3389/fimmu.2023.1254158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620737/
https://www.ncbi.nlm.nih.gov/pubmed/37928530
http://dx.doi.org/10.3389/fimmu.2023.1254158

Ejemplares similares